Research is emerging on various treatments and biomarkers for liver diseases, including the use of NILDAs. Other studies are focused on treatments for conditions such as fatty liver disease, decompensated cirrhosis, and chronic hepatitis B and delta. The field of liver disease research appears to be active, with new findings and recommendations being reported, although the specific implications and connections between these developments are unclear.